← Open Payments lookup

SADIA CHEEMA: Open Payments

NPI 1144873043 · GAMBRILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,038 in 94 payments from 17 companies in 2025. Trend: 2023 $764 · 2024 $1,398 · 2025 $2,038

Food & beverage: $2,029Education: $9
CompanyPaymentsAmount
ABBVIE INC.14$311
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$293
Alkermes, Inc.15$259
Indivior Inc.8$218
Lundbeck LLC10$210
Vanda Pharmaceuticals Inc.7$173
Teva Pharmaceuticals USA, Inc.4$103
Supernus Pharmaceuticals, Inc.5$103
E.R. Squibb & Sons, L.L.C.3$73
Takeda Pharmaceuticals U.S.A., Inc.3$72

Products named: VRAYLAR, CAPLYTA, REXULTI, SUBLOCADE, HETLIOZ, ARISTADA, AUSTEDO XR, Qelbree.

Industry payments across MD — which companies pay providers there.